Ammonett Pharma LLC
Midlothian
Virginia
United States
About Ammonett Pharma LLC
Ammonett Pharma LLC, is a privately held biopharmaceutical company focused on the development of novel therapies restoring normal growth and metabolism. Oratrope is Ammonett’s lead product, targeting children with PGHD who have an intact hypothalamic pituitary GH axis.LEADERSHIP:
Founder and CSO: Michael Thorner
3 articles about Ammonett Pharma LLC
-
Lumos Pharma Acquires Candidate for Oral Treatment of Growth Hormone Deficiency
9/24/2018
LUM-201 is an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland
-
Ammonett Pharma Granted Orphan Drug Designation From The U.S. FDA For Ibutamoren Mesylate (MK-0677) For Treatment Of Growth Hormone Deficiency
6/19/2017
-
Ammonett Pharma Receives Notice Of Allowance Of U.S. Patent For Oratrope Related To Detecting And Treating Growth Hormone Deficiency
5/25/2017